Position in RDY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,490
+$640 QoQ
Shares Held
1,000
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#203
of 238 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BROWN BROTHERS HARRIMAN & CO holds $96,941,137 across 13 Drug Manufacturers - Specialty & Generic names. RDY ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,332,672 | $95,765,809 | |
| 2 | VTRS |
Viatris Inc
|
50,553 | $802,781 | |
| 3 | HLN |
Haleon plc
|
16,242 | $151,537 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
9,333 | $149,607 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
40 | $21,673 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
This page
|
1,000 | $14,490 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
384 | $13,009 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
187 | $8,697 |
All Filings in RDY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,490 | 1,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $13,850 | 1,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,040 | 1,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $6,990 | 500 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $14,443 | 961 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||